BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28441645)

  • 1. Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation.
    Tanaka A; Jabbour RJ; Giannini F; Latib A; Colombo A
    J Invasive Cardiol; 2017 May; 29(5):E63. PubMed ID: 28441645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staged stenting of a long aneurysm of a saphenous vein coronary artery bypass graft.
    Jamshidi P; Resink T; Erne P
    J Invasive Cardiol; 2008 Jan; 20(1):E1-5. PubMed ID: 18174622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
    Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
    Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrograde dilatation of a totally occluded ostial left anterior descending artery from saphenous venous graft in the descending aorta following stenting of the aorto-ostial graft restenosis in a patient with left main coronary artery stenosis.
    Cheng NJ; Chang CJ; Ho WJ
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):357-60. PubMed ID: 12822159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral valve endocarditis resulting from coagulase-negative Staphylococcus after stent implantation in a saphenous vein graft.
    Palmer ND; Ramsdale DR
    Cardiol Rev; 2005; 13(3):152-4. PubMed ID: 15831150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
    Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A completely fractured zotarolimus-eluting stent in an aortocoronary saphenous vein bypass graft.
    Venero CV; Aligeti VR; Wortham DC
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):62-5. PubMed ID: 22553171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous restenosis of Taxus and Cypher drug-eluting stents.
    Nilsson KR; Gharacholou SM; Sketch MH; Krucoff MW
    J Invasive Cardiol; 2006 Nov; 18(11):557-60. PubMed ID: 17090822
    [No Abstract]   [Full Text] [Related]  

  • 12. Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
    Nauta ST; Van Mieghem NM; Magro M; Deckers JW; Simsek C; Van Geuns RJ; Van Der Giessen WJ; De Jaegere P; Regar E; Van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2012 May; 79(6):912-8. PubMed ID: 21542111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality imaging evaluation of saphenous vein graft peri-stent contrast staining enlargement.
    Shibata N; Sugiura T; Tanaka A; Shimizu K
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2105-2106. PubMed ID: 32686029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidewire Self-Extrusion After Entrapment of Distal Protection Device During Saphenous Vein Graft Angioplasty.
    Wainstein RV; Homem Valle F; Pivatto Júnior F; Morzoletto Pedrollo I; Carlos Corsetti Bergoli L; Vugman Wainstein M
    JACC Cardiovasc Interv; 2017 Jan; 10(1):e3-e5. PubMed ID: 28017316
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions.
    Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(3):183-7. PubMed ID: 19595401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 17. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.